Search Results | Showing 31 - 40 of 42 results for "Life sciences" |
| | | ... currently invests through a number of fund managers, including Brandon Capital Partners which invests solely in life sciences ventures and also counts Australian Super, HESTA and Statewide Super among its investors, along with the Commonwealth of Australia. ... |
| | | | ... In the 2015 financial year, $46 million was invested by venture capital funds into the Australian healthcare and life sciences sector. |
| | | | ... partner at CM Capital Investments, an institutionally backed venture capital company focused on the biotechnology, life sciences, telecommunications, information technology and renewable energy sectors. He has held directorships on numerous companies ... |
| | | | ... Partners. Private investors are matching the government's investment in the funds that will help innovative new life sciences, IT and medical research companies get off the ground. Under the IIF programme, venture capital funds receive a ten year licence ... |
| | | | ... investors." According to UKTI, there are all sorts of investment opportunities presenting themselves in the UK with life sciences, energy, environment and media sectors attracting investor interest. While the established ties between Australia and Britain ... |
| | | | ... financial services had the highest growth rate, with a 39 per cent increase compared with technology (37 per cent), life sciences/healthcare (26 per cent) and consumer (25 per cent). Jason Johnson, managing partner of Johnson Executive Search and director ... |
| | | | ... no economic data scheduled for release on Friday. In equities news, MaxiTRANS Industries Ltd, Korvest Ltd, Narhex Life Sciences Ltd, Buru Energy Ltd, Biotron Ltd and Datadot Technology Ltd hold annual general meetings. News Corporation Ltd holds its ... |
| | | | ... together for nearly a decade and members possess complementary skills as well as a deep knowledge and experience in life sciences, clinical development, medical device development and realising effective exits." The fund invests in companies that will ... |
| | | | ... shying away from the industry. Speaking at the Excellence in Biotechnology Investment conference yesterday, Strategic Life Sciences chief investment officer Graeme Kaufman said the local biotechnology industry presents vast investment opportunities for ... |
| | | | ... Ltd, will release third quarter sales results, with market players hoping to get a review of the ownership process. Life sciences company Nanosonics and base metal explorer Peel Exploration Ltd list on the ASX. Yesterday, the S&P/ASX200 index finished ... |
|